Source: Eur Respir J 2009; 33: 3-5
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Beasley R., Martinez F. D., Hackshaw A., Rabe K. F., Sterk P. J., Djukanovic R.. Safety of long-acting β-agonists: urgent need to clear the air remains. Eur Respir J 2009; 33: 3-5

Member's Comments

No comment yet.

Related content which might interest you: The issues and the controversies: are we really ready for on-demand use of ICS? Source: Annual Congress 2013 –Inhaled corticosteroids for asthma: on-demand or continuous use? Year: 2013 Inhaler technique: An unmet need in patients with difficult asthma? Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics Year: 2013 Investigating the steroids and long-acting β2-agonists combination: why do we need more? Source: Eur Respir J 2004; 23: 501-502 Year: 2004 Is it feasible for respiratory physiologists to carry out inhaler device technique checks during routine pulmonary function tests? Source: International Congress 2016 – Man versus machine: waves, frequency, and more in lung function Year: 2016 The sustainability agenda and inhaled therapy: what do patients want? Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence Year: 2021 Long-acting β-agonists: a review of formoterol safety data from asthma clinical trials Source: Eur Respir J 2009; 33: 21-32 Year: 2009 Lung function testing in the COVID era: safety concerns you should consider Source: COVID-19 Videos Year: 2020 Validation of a new inhaled therapeutic algorithm for the stable COPD patient: The COPD easy treatment project Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care Year: 2015 Asthma and once-daily administration of inhaled corticosteroids: potential for improved compliance and reduced health costs Source: Eur Respir J 2002; 20: Suppl. 38, 305s Year: 2002 Getting approval for new therapeutic medical devices versus drugs: are the differences justified? Source: Eur Respir Rev 2016; 25: 223-226 Year: 2016 The effect of adding inhaled corticosteroids to long-acting bronchodilators for COPD: A real practice analysis in Italy Source: International Congress 2014 – Prevalence of COPD and mortality from COPD Year: 2014 Is a more frequent use of small volume nebulizer aerosol during hospitalisation by respiratory nurses a guarantee for better adherence to aerosol guidelines? Source: Annual Congress 2010 - The nursing challenges and strategies when caring for patients with chronic lung disease Year: 2010 “I don’t think there’s a simple way of doing it:” the use of an electronic alert to identify excessive prescribing of short-acting beta2-agonists for people with asthma – a qualitative study with asthma experts and primary care staff Source: Virtual Congress 2020 – Diagnosis and management of airways disease in primary care Year: 2020 Safety profile of glycopyrronium in patients with COPD: An innovative approach to analyse data from post-marketing surveillance (PMS) Source: International Congress 2014 – Asthma and COPD management Year: 2014 Inhaled corticosteroids - widely prescribed in early life despite little data on safety and efficacy Source: Eur Respir J 2001; 18: Suppl. 33, 523s Year: 2001 Home nebulizers: outcome of 151 inhaled therapy optimization assessments using methodology recommended in ERS nebulizer guidelines Source: Eur Respir J 2002; 20: Suppl. 38, 234s Year: 2002 Electronic monitoring of adherence to inhaled corticosteroids: an essential tool in identifying severe asthma in children Source: Eur Respir J, 50 (6) 1700910; 10.1183/13993003.00910-2017 Year: 2017 PAH: what surgeons can offer when medication fails Source: Annual Congress 2013 –What's new in thoracic surgery: highlights for the pulmonologist Year: 2013 Protocol of early mobilization and rehabilitation in critical patients using inotropic medications: Is it really safe? Our hands on practice! Source: International Congress 2019 – Exercise and rehabilitation in patients with acute and chronic respiratory diseases Year: 2019